Indication
For treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age
Medicine details
- Medicine name:
- linzagolix (Yselty)
- SMC ID:
- SMC2631
- Pharmaceutical company
- Theramex UK LTD
- BNF chapter
- Obstetrics, gynaecology, and urinary-tract disorders
- Submission type
- Full
- Publication due date:
- TBC
- SMC meeting date:
- 02 April 2024
- Patient group submission deadline:
- TBC